Hospital Consumed Your Stents or Ortho Implants in OT Without Raising a PO? Consignment Stock & Receivable Recovery Guide

Every cardiac stent, orthopedic joint, spine pedicle screw, and intraocular lens (IOL) distributor across India operates under an operational anomaly that threatens commercial solvency: the hospital consignment stocking model. To ensure life-saving surgical implants are available 24 hours a day for emergency primary angioplasties (PAMI) and poly-trauma stabilization, authorized distributors place crores of rupees worth of high-value implants inside hospital Cath-Labs, CSSD units, and Operation Theatres (OT) on provisional Delivery Challans.

Under clinical norms, when a surgeon implants a Drug-Eluting Stent (DES) or total knee arthroplasty kit into a patient, the hospital billing department immediately captures the implant in the patient's final hospital invoice. Cash-paying patients clear the bill before discharge; corporate and insurance patients have their claims submitted to Third-Party Administrators (TPAs). Yet, when the distributor submits the corresponding Delivery Challan and asks the hospital procurement department to generate a formal Purchase Order (PO) and Goods Receipt Note (GRN) so a tax invoice can be raised, the institutional excuses begin:

• The “Internal Requisition Pending” Delay:The purchase department asserts that the operating surgeon hasn't signed the internal consumption slip or that the Cath-Lab nurse hasn't forwarded the physical barcode sticker register.
• The “TPA Settlement Pre-Condition” Excuse:Hospital finance refuses to process the distributor's bill until the patient's insurance claim or government scheme (such as CGHS, ECHS, or Ayushman Bharat PM-JAY) is audited and disbursed 6 to 12 months later.
• The Retroactive Trade Margin Squeeze: Hospital CFOs attempt to unilaterally enforce post-billing price cuts, citing National Pharmaceutical Pricing Authority (NPPA) ceiling revisions under the Drugs (Prices Control) Order, 2013 (DPCO), forcing distributors to accept 20% to 35% arbitrary deductions.
• The Detained Loaner Instrumentation Trap:Proprietary surgical instruments, trial sets, reamers, and drill guides worth ₹10 Lakh to ₹30 Lakh are detained inside the hospital's CSSD or OT, preventing the distributor from servicing other surgical centers.

This operational stalemate is not merely an administrative delay—it is an unlawful commercial detention. Under Indian commercial law, hospital purchase departments have no legal authority to treat surgical distributors as interest-free working capital lenders. By applying Section 24(a) of the Sale of Goods Act, 1930, the statutory protections of the MSMED Act, 2006, and penal remedies under the Bharatiya Nyaya Sanhita, 2023, implant distributors can pierce hospital procurement bureaucracy and recover their hard-earned dues with statutory compound interest.

In traditional B2B debt litigation, a creditor proves supply via a signed Goods Receipt Note (GRN) and a physical invoice counter-stamped by the security gate. In hospital implant consignment, however, hospitals deliberately refuse to issue a GRN until their purchase team raises a PO. To obtain summary decrees and enforce pre-judgment attachments, implant distributors must build an airtight electronic audit trail under Section 63 of the Bharatiya Sakshya Adhiniyam, 2023 (BSA).

When your legal counsel serves an Advocate Demand Notice supported by an affidavit under BSA Section 63 authenticating these high-resolution OT register photographs, the hospital's administrative defense of “stock unverified” collapses instantly. In commercial court, the burden shifts entirely to the hospital to explain how an implant registered in its patient discharge file was not consumed.

Spine pedicle screw procedures, acetabular hip reconstructions, and complex maxillofacial surgeries require specialized surgical instrumentation sets—including pedicle probes, tap guides, rod benders, torque wrenches, and reamer handles. Distributors deliver these multi-tray sets (frequently valued at ₹8 Lakh to ₹35 Lakh per set) on a loaner or demo basis for the surgery.

A chronic failure mode occurs when hospital CSSD units retain the instrumentation trays for weeks following surgery, misplace critical titanium screws, or refuse to release the sets until the distributor agrees to arbitrary billing discounts on the consumed implants.

Our legal protocol involves serving an urgent 48-Hour Biomedical Asset Repossession Noticeestablishing running commercial demurrage of ₹3,500 to ₹7,500 per day. If the hospital fails to tender immediate release, we initiate criminal complaints before the jurisdictional Chief Judicial Magistrate under Section 175 BNSS while moving the Commercial Court under Order XL Rule 1 CPC for an ex-parte Court Commissioner to enter the hospital and repossess the distributor's property.

When pressed for settlement, hospital financial controllers routinely deploy two standard statutory misinterpretations. Our pre-litigation notices dismantle these pretexts on Day 1:

For an in-depth breakdown of mandatory 45-day commercial payment compliance, review our statutory guide on Section 43B(h) MSME Payment Rules & Tax Deductions and calculate potential delayed payment interest using our MSME Delayed Payment Interest Calculator.